Company Profile
Tactile Systems Technology, Inc. Stock Price, News & Analysis
- Ticker:
- TCMD
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Tactile Systems Technology sits inside the cell therapy universe where trial execution and regulatory timing can change the investment case quickly.
Stock performance
26.45 USD (+0.88%)
Close
Last updated: June 23, 2026 at 00:00
596.61M USD
Market cap
Why the stock is moving
TCMD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Tactile Systems Technology sits inside the cell therapy universe where trial execution and regulatory timing can change the investment case quickly.
Business Model Characteristics
Tactile Systems Technology follows a platform-led model where readouts, manufacturing progress, and commercialization milestones matter as much as the initial science. The market tends to reprice the stock quickly whenever adoption, safety, or label-expansion signals improve.
Position Within the Biotechnology Landscape
Compared with larger diversified biotech peers, Tactile Systems Technology sits at the high-catalyst end of the landscape, where cell therapy names can move sharply on data, approvals, and launch milestones.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy
Source: Tactile Systems Technology, Inc.
- 02
Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference
Source: Tactile Systems Technology, Inc.
- 03
Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025
Source: Tactile Systems Technology, Inc.
- 04
Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema
Source: Tactile Systems Technology, Inc.
- 05
Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
Source: Tactile Systems Technology, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Tactile Systems Technology, Inc. (TCMD)?
Tactile Systems Technology, Inc. (TCMD) most recently closed at 26.45 USD, a +0.88% move versus the previous session.
What is the market cap of Tactile Systems Technology, Inc. (TCMD)?
Tactile Systems Technology, Inc. currently has a market capitalization of 596.61M USD on BioPharmSignal.
What does Tactile Systems Technology, Inc. do?
Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
On which exchange is TCMD stock listed?
Tactile Systems Technology, Inc. (TCMD) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Tactile Systems Technology sits inside the cell therapy universe where trial execution and regulatory timing can change the investment case quickly., Biotechnology.
What is Tactile?
Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases.
Which conditions is Tactile Systems Technology, Inc. targeting with Tactile?
Tactile Systems Technology, Inc. is associated with oncology based on its company overview and current catalyst commentary.
What is Systems?
Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases.
What is Technology?
Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases.